Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies

J Zhang, Y Zhang, J Wang, Y Xia, J Zhang… - Signal transduction and …, 2024 - nature.com
Alzheimer's disease (AD) stands as the predominant form of dementia, presenting significant
and escalating global challenges. Its etiology is intricate and diverse, stemming from a …

The gut microbiome in Alzheimer's disease: what we know and what remains to be explored

S Chandra, SS Sisodia, RJ Vassar - Molecular neurodegeneration, 2023 - Springer
Abstract Alzheimer's disease (AD), the most common cause of dementia, results in a
sustained decline in cognition. There are currently few effective disease modifying therapies …

Skin bioelectronics towards long-term, continuous health monitoring

Y Wang, H Haick, S Guo, C Wang, S Lee… - Chemical Society …, 2022 - pubs.rsc.org
Skin bioelectronics are considered as an ideal platform for personalised healthcare because
of their unique characteristics, such as thinness, light weight, good biocompatibility …

Machine learning for dementia prediction: a systematic review and future research directions

A Javeed, AL Dallora, JS Berglund, A Ali, L Ali… - Journal of medical …, 2023 - Springer
Abstract Nowadays, Artificial Intelligence (AI) and machine learning (ML) have successfully
provided automated solutions to numerous real-world problems. Healthcare is one of the …

[HTML][HTML] Lipid accumulation induced by APOE4 impairs microglial surveillance of neuronal-network activity

MB Victor, N Leary, X Luna, HS Meharena… - Cell Stem Cell, 2022 - cell.com
Summary Apolipoprotein E4 (APOE4) is the greatest known genetic risk factor for
developing sporadic Alzheimer's disease. How the interaction of APOE4 microglia with …

Lipid metabolism and Alzheimer's disease: clinical evidence, mechanistic link and therapeutic promise

F Yin - The FEBS journal, 2023 - Wiley Online Library
Alzheimer's disease (AD) is an age‐associated neurodegenerative disorder with
multifactorial etiology, intersecting genetic and environmental risk factors, and a lack of …

Cholesterol and Alzheimer's disease; from risk genes to pathological effects

FM Feringa, R Van der Kant - Frontiers in Aging Neuroscience, 2021 - frontiersin.org
While the central nervous system compromises 2% of our body weight, it harbors up to 25%
of the body's cholesterol. Cholesterol levels in the brain are tightly regulated for …

[HTML][HTML] Alzheimer's disease as a viral disease: Revisiting the infectious hypothesis

F Bruno, P Abondio, R Bruno, L Ceraudo… - Ageing research …, 2023 - Elsevier
Alzheimer's disease (AD) represents the most frequent type of dementia in elderly people.
Two major forms of the disease exist: sporadic-the causes of which have not yet been fully …

Cholesterol metabolism in aging and age-related disorders

G Saher - Annual Review of Neuroscience, 2023 - annualreviews.org
All mammalian cell membranes contain cholesterol to maintain membrane integrity. The
transport of this hydrophobic lipid is mediated by lipoproteins. Cholesterol is especially …

Brain cell type-specific cholesterol metabolism and implications for learning and memory

D Li, J Zhang, Q Liu - Trends in neurosciences, 2022 - cell.com
Cholesterol homeostasis is vital for brain function. Brain cholesterol is locally synthesized,
with varying synthesis capacities across different cell types. Moreover, brain cholesterol …